A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells

被引:158
作者
Roose, JP
Mollenauer, M
Gupta, VA
Stone, J
Weiss, A
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA
[6] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2G7, Canada
关键词
D O I
10.1128/MCB.25.11.4426-4441.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras GTPases are on/off switches regulating numerous cellular responses by signaling to various effector molecules. In T lymphocytes, Ras can be activated by two Ras exchange factors, SOS and RasGRP1, which are recruited through the adapters Grb2 and LAT and via the second-messenger diacylglycerol (DAG), respectively. Mitogen-activated protein (MAP) kinase phosphorylation patterns induced by active Ras can vary and contribute to distinct cellular responses. The different consequences of Ras activation by either guanine exchange factor are unknown. DAG also recruits and activates the kinase protein kinase CO (PKCO) turning on the Erk MAP kinase pathway, but the biochemical mechanism responsible is unclear. We generated T-cell clones deficient in phorbol myristate acetate (a surrogate for DAG)-induced Ras activation. Analysis of a RasGRP1-deficient Jurkat T-cell clone and RasGRP1 RNA interference in wild-type cells revealed that RasGRP1 is required for optimal, antigen receptor-triggered Ras-Erk activation. RasGRP1 relies on its DAG-binding domain to selectively activate Erk kinases. Activation of Erk correlates with the phosphorylation of threonine residue 184 in RasGRP1. This phosphorylation event requires the activities of novel PKC kinases. Conversely, active PKCO depends on RasGRP1 sufficiency to effectively trigger downstream events. Last, DAG-PKC-RasGRP1-driven Ras-Erk activation in T cells is a unique signaling event, not simply compensated for by SOS activity.
引用
收藏
页码:4426 / 4441
页数:16
相关论文
共 51 条
[1]   Activation of RasGRP3 by phosphorylation of Thr-133 is required ifor B cell receptor-mediated Ras activation [J].
Aiba, Y ;
Oh-hora, M ;
Kiyonaka, S ;
Kimura, Y ;
Hijikata, A ;
Mori, Y ;
Kurosaki, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (47) :16612-16617
[2]   Protein kinase Cθ:: a new essential superstar on the T-cell stage [J].
Altman, A ;
Isakov, N ;
Baier, G .
IMMUNOLOGY TODAY, 2000, 21 (11) :567-573
[3]   Protein kinase C-θ (PKCθ):: it's all about location, location, location [J].
Altman, A ;
Villalba, M .
IMMUNOLOGICAL REVIEWS, 2003, 192 (01) :53-63
[4]   Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1 [J].
Bivona, TG ;
Perez de Castro, I ;
Ahearn, IM ;
Grana, TM ;
Chiu, VK ;
Lockyer, PJ ;
Cullen, PJ ;
Pellicer, A ;
Cox, AD ;
Philips, MR .
NATURE, 2003, 424 (6949) :694-698
[5]   All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral [J].
Bos, JL .
EMBO JOURNAL, 1998, 17 (23) :6776-6782
[6]  
BOS JL, 1989, CANCER RES, V49, P4682
[7]   PKCδ associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters [J].
Brodie, C ;
Steinhart, R ;
Kazimirsky, G ;
Rubinfeld, H ;
Hyman, T ;
Ayres, JN ;
Hur, GM ;
Toth, A ;
Yang, DZ ;
Garfield, SH ;
Stone, JC ;
Blumberg, PM .
MOLECULAR PHARMACOLOGY, 2004, 66 (01) :76-84
[8]   Divergent and convergent signaling by the diacylglycerol second messenger pathway in mammals [J].
Brose, N ;
Betz, A ;
Wegmeyer, H .
CURRENT OPINION IN NEUROBIOLOGY, 2004, 14 (03) :328-340
[9]   Exchange factors of the RasGRP family mediate Ras activation in the Golgi [J].
Caloca, MJ ;
Zugaza, JL ;
Bustelo, XR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :33465-33473
[10]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413